Transplanting the elderly: Balancing aging with histocompatibility

Transplantation Reviews

Volumn 29, Issue 4, 2015, Pages 205-211

  Dreyer, G J ^a   Hemke, A C ^b   Reinders, M E J ^a   de Fijter, J W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Dutch Transplant Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; DONOR; END STAGE RENAL DISEASE; GERIATRIC PATIENT; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE ACCESS; HEALTH PROGRAM; HISTOCOMPATIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; RENAL REPLACEMENT THERAPY; REVIEW; HEALTH CARE DELIVERY; HISTOCOMPATIBILITY TEST; HOSPITAL ADMISSION; IMMUNOLOGY; INCIDENCE; KIDNEY FAILURE, CHRONIC; MORTALITY; PATIENT SELECTION; QUALITY OF LIFE; REGISTER; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION;

IMMUNOSUPPRESSIVE AGENT;

AGED; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH SERVICES ACCESSIBILITY; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PATIENT SELECTION; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84960458743     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2015.08.003     Document Type: Review

References (92)

1. United Nations, Department of Economic and Social Affairs, Population Division World Urbanization Prospects: The 2014 Revision, Highlights (ST/ESA/SER.A/352) 2014.
2. United States Renal Data System 2014 Annual data report: An overview of the epidemiology of kidney disease in the United States 2014, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
3. Wolfe R.A., Ashby V.B., Milford E.L., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999, 341:1725-1730.
4. Rao P.S., Merion R.M., Ashby V.B., Port F.K., Wolfe R.A., Kayler L.K. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation 2007, 83:1069-1074.
5. Ojo A.O., Hanson J.A., Meier-Kriesche H., et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001, 12:589-597.
6. Oniscu G.C., Brown H., Forsythe J.L. Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005, 16:1859-1865.
7. Humar A., Denny R., Matas A.J., Najarian J.S. Graft and quality of life outcomes in older recipients of a kidney transplant. Exp Clin Transplant 2003, 1:69-72.
8. Cornella C., Brustia M., Lazzarich E., et al. Quality of life in renal transplant patients over 60 years of age. Transplant Proc 2008, 40:1865-1866.
9. Oniscu G.C., Brown H., Forsythe J.L. How great is the survival advantage of transplantation over dialysis in elderly patients?. Nephrol Dial Transplant 2004, 19:945-951.
10. de Fijter J.W. The impact of age on rejection in kidney transplantation. Drugs Aging 2005, 22:433-449.
11. Molnar M.Z., Streja E., Kovesdy C.P., et al. Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis 2012, 59:841-848.
12. Oniscu G.C., Brown H., Forsythe J.L. How old is old for transplantation?. Am J Transplant 2004, 4:2067-2074.
13. Foss A., Heldal K., Scott H., et al. Kidneys from deceased donors more than 75 years perform acceptably after transplantation. Transplantation 2009, 87:1437-1441.
14. Heldal K., Leivestad T., Hartmann A., Svendsen M.V., Lien B.H., Midtvedt K. Kidney transplantation in the elderly - the Norwegian experience. Nephrol Dial Transplant 2008, 23:1026-1031.
15. Keith D.S., Cantarovich M., Paraskevas S., Tchervenkov J. Recipient age and risk of chronic allograft nephropathy in primary deceased donor kidney transplant. Transpl Int 2006, 19:649-656.
16. Mendonca H.M., Dos Reis M.A., de Castro de Cintra Sesso R., Camara N.O., Pacheco-Silva A. Renal transplantation outcomes: a comparative analysis between elderly and younger recipients. Clin Transplant 2007, 21:755-760.
17. Tullius S.G., Tran H., Guleria I., Malek S.K., Tilney N.L., Milford E. The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. Ann Surg 2010, 252:662-674.
18. Huang E., Poommipanit N., Sampaio M.S., et al. Intermediate-term outcomes associated with kidney transplantation in recipients 80 years and older: an analysis of the OPTN/UNOS database. Transplantation 2010, 90:974-979.
19. Meier-Kriesche H.U., Ojo A.O., Hanson J.A., Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 2001, 59:1539-1543.
20. Gill J., Bunnapradist S., Danovitch G.M., Gjertson D., Gill J.S., Cecka M. Outcomes of kidney transplantation from older living donors to older recipients. Am J Kidney Dis 2008, 52:541-552.
21. Ojo A.O., Hanson J.A., Wolfe R.A., Leichtman A.B., Agodoa L.Y., Port F.K. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000, 57:307-313.
22. Rebollo P., Ortega F., Baltar J.M., et al. Health-related quality of life (HRQOL) in end stage renal disease (ESRD) patients over 65 years. Geriatr Nephrol Urol 1998, 8:85-94.
23. Matas A.J., Smith J.M., Skeans M.A., et al. OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant 2014, 14:11-44.
24. Matas A.J., Smith J.M., Skeans M.A., et al. OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant 2015, 15:1-34.
25. Knoll G.A. Kidney transplantation in the older adult. Am J Kidney Dis 2013, 61:790-797.
26. Akolekar D., Forsythe J.L., Oniscu G.C. Impact of patient characteristics and comorbidity profile on activation of patients on the kidney transplantation waiting list. Transplant Proc 2013, 45:2115-2122.
27. Bayat S., Frimat L., Thilly N., Loos C., Briancon S., Kessler M. Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care. Nephrol Dial Transplant 2006, 21:2900-2907.
28. Szeifert L., Bragg-Gresham J.L., Thumma J., et al. Psychosocial variables are associated with being wait-listed, but not with receiving a kidney transplant in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2012, 27:2107-2113.
29. Dudley C.R., Johnson R.J., Thomas H.L., Ravanan R., Ansell D. Factors that influence access to the national renal transplant waiting list. Transplantation 2009, 88:96-102.
30. Udayaraj U., Ben-Shlomo Y., Roderick P., et al. Social deprivation, ethnicity, and access to the deceased donor kidney transplant waiting list in England and Wales. Transplantation 2010, 90:279-285.
31. Effros R.B. Costimulatory mechanisms in the elderly. Vaccine 2000, 18:1661-1665.
32. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Quaglino D. Immunological changes in the elderly. Aging (Milano) 1999, 11:281-286.
33. Globerson A., Effros R.B. Ageing of lymphocytes and lymphocytes in the aged. Immunol Today 2000, 21:515-521.
34. McKay D., Jameson J. Kidney transplantation and the ageing immune system. Nat Rev Nephrol 2012, 8:700-708.
35. Meier-Kriesche H.U., Ojo A., Hanson J., et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 2000, 69:885-889.
36. Cecka J.M. The OPTN/UNOS Renal Transplant Registry. Clin Transpl 2005, 1-16.
37. de Fijter J.W., Mallat M.J., Doxiadis I.I., et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001, 12:1538-1546.
38. Meier-Kriesche H.U., Srinivas T.R., Kaplan B. Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 2001, 33:3425-3426.
39. Heldal K., Hartmann A., Leivestad T., et al. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 2009, 87:1045-1051.
40. Gavazzi G., Krause K.H. Ageing and infection. Lancet Infect Dis 2002, 2:659-666.
41. Martins P.N., Pratschke J., Pascher A., et al. Age and immune response in organ transplantation. Transplantation 2005, 79:127-132.
42. Trouillhet I., Benito N., Cervera C., et al. Influence of age in renal transplant infections: cases and controls study. Transplantation 2005, 80:989-992.
43. Kauffman H.M., McBride M.A., Cors C.S., Roza A.M., Wynn J.J. Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation 2007, 83:404-410.
44. Frei U., Noeldeke J., Machold-Fabrizii V., et al. Prospective age-matching in elderly kidney transplant recipients - a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008, 8:50-57.
45. de Fijter J.W. An old virtue to improve senior programs. Transpl Int 2009, 22:259-268.
46. Pascual J., Zamora J., Pirsch J.D. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008, 52:553-586.
47. Sung R.S., Guidinger M.K., Leichtman A.B., et al. Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation 2007, 84:1138-1144.
48. Merion R.M., Ashby V.B., Wolfe R.A., et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005, 294:2726-2733.
49. Terasaki P.I., Gjertson D.W., Cecka J.M., Takemoto S., Cho Y.W. Significance of the donor age effect on kidney transplants. Clin Transplant 1997, 11:366-372.
50. Meier-Kriesche H.U., Ojo A.O., Cibrik D.M., et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000, 70:306-310.
51. Chavalitdhamrong D., Gill J., Takemoto S., et al. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database. Transplantation 2008, 85:1573-1579.
52. Waiser J., Schreiber M., Budde K., et al. Age-matching in renal transplantation. Nephrol Dial Transplant 2000, 15:696-700.
53. Kasiske B.L., Snyder J. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002, 13:1067-1072.
54. Boom H., Mallat M.J., de Fijter J.W., Zwinderman A.H., Paul L.C. Delayed graft function influences renal function, but not survival. Kidney Int 2000, 58:859-866.
55. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995, 345:1321-1325.
56. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996, 61:1029-1037.
57. van Saase J.L., van der Woude F.J., Thorogood J., et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995, 59:1280-1285.
58. Kappel B., Olsen S. Cortical interstitial tissue and sclerosed glomeruli in the normal human kidney, related to age and sex. A quantitative study. Virchows Arch A Pathol Anat Histol 1980, 387:271-277.
59. Nyengaard J.R., Bendtsen T.F. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992, 232:194-201.
60. Seron D., Carrera M., Grino J.M., et al. Relationship between donor renal interstitial surface and post-transplant function. Nephrol Dial Transplant 1993, 8:539-543.
61. Lindeman R.D., Tobin J., Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985, 33:278-285.
62. Lamb K.E., Lodhi S., Meier-Kriesche H.U. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2011, 11:450-462.
63. Solez K., Colvin R.B., Racusen L.C., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
64. Meier-Kriesche H., Ojo A.O., Arndorfer J.A., et al. Recipient age as an independent risk factor for chronic renal allograft failure. Transplant Proc 2001, 33:1113-1114.
65. Einecke G., Sis B., Reeve J., et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009, 9:2520-2531.
66. Gaston R.S., Cecka J.M., Kasiske B.L., et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010, 90:68-74.
67. Terasaki P.I., Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol 2005, 17:541-545.
68. Terasaki P.I., Cai J. Human leukocyte antigen antibodies and chronic rejection: from association to causation. Transplantation 2008, 86:377-383.
69. Halloran P.F., Reeve J.P., Pereira A.B., Hidalgo L.G., Famulski K.S. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the genome Canada studies of kidney transplant biopsies. Kidney Int 2014, 85:258-264.
70. Lachmann N., Terasaki P.I., Budde K., et al. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009, 87:1505-1513.
71. Haas M., Sis B., Racusen L.C., et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014, 14:272-283.
72. Connolly J.K., Dyer P.A., Martin S., Parrott N.R., Pearson R.C., Johnson R.W. Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation. Transplantation 1996, 61:709-714.
73. Taylor C.J., Welsh K.I., Gray C.M., et al. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit. Clin Transpl 1993, 233-241.
74. Wiebe C., Gibson I.W., Blydt-Hansen T.D., et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012, 12:1157-1167.
75. Everly M.J., Rebellato L.M., Haisch C.E., et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation 2013, 95:410-417.
76. Willicombe M., Brookes P., Sergeant R., et al. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation 2012, 94:172-177.
77. Loupy A., Lefaucheur C., Vernerey D., et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013, 369:1215-1226.
78. Freitas M.C., Rebellato L.M., Ozawa M., et al. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes. Transplantation 2013, 95:1113-1119.
79. Navarrete C., Jaraquemada D., Fainboim L., et al. Genetic and functional relationship of the HLA-DR and HLA-DQ antigens. Immunogenetics 1985, 21:97-101.
80. Freedman B.I., Thacker L.R., Heise E.R., Adams P.L. HLA-DQ matching in cadaveric renal transplantation. Clin Transplant 1997, 11:480-484.
81. Cecka J.M. The changing role of HLA matching. Clin Transpl 1986, 141-155.
82. Takemoto S., Port F.K., Claas F.H., Duquesnoy R.J. HLA matching for kidney transplantation. Hum Immunol 2004, 65:1489-1505.
83. Takemoto S.K., Terasaki P.I., Gjertson D.W., Cecka J.M. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000, 343:1078-1084.
84. Doxiadis I.I., Smits J.M., Persijn G.G., Frei U., Claas F.H. It takes six to boogie: allocating cadaver kidneys in Eurotransplant. Transplantation 2004, 77:615-617.
85. Johnson R.J., Fuggle S.V., O'Neill J., et al. Factors influencing outcome after deceased heart beating donor kidney transplantation in the United Kingdom: an evidence base for a new national kidney allocation policy. Transplantation 2010, 89:379-386.
86. Chang P., Gill J., Dong J., et al. Living donor age and kidney allograft half-life: implications for living donor paired exchange programs. Clin J Am Soc Nephrol 2012, 7:835-841.
87. Kauffman H.M., Bennett L.E., McBride M.A., Ellison M.D. The expanded donor. Transplant Rev 1997, 11:165-190.
88. OPAT Network Policies: allocation of kidneys 2014.
89. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995, 333:333-336.
90. Halloran P.F., Homik J., Goes N., et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997, 29:79-81.
91. Penfield J.G., Wang Y., Li S., et al. Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int 1999, 56:1759-1769.
92. Lu C.Y., Penfield J.G., Kielar M.L., Vazquez M.A., Jeyarajah D.R. Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process?. Kidney Int 1999, 55:2157-2168.